Skinrange Addiction Killer Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-05-2024
- Paid Up Capital ₹ 0.10 M
as on 30-05-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1074.00%
(FY 2022)
- Profit 2409.50%
(FY 2022)
- Ebitda -1049.90%
(FY 2022)
- Net Worth 2.41%
(FY 2022)
- Total Assets 14.21%
(FY 2022)
About Skinrange Addiction Killer Foundation
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shazia Khan and Geetanjali serve as directors at the Company.
- CIN/LLPIN
U85300DL2020NPL374333
- Company No.
374333
- Company Classification
Private Not For Profit Company
- Incorporation Date
09 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skinrange Addiction Killer Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shazia Khan  | Additional Director | Current | |
| Geetanjali | Director | 10-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Skinrange Addiction Killer Foundation.
Skinrange Addiction Killer Foundation, for the financial year ended 2022, experienced significant growth in revenue, with a 1074% increase. The company also saw a substantial improvement in profitability, with a 2409.5% increase in profit. The company's net worth moved up by a moderate rise of 2.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skinrange Addiction Killer Foundation?
Unlock access to Skinrange Addiction Killer Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skinrange Addiction Killer Foundation?
Skinrange Addiction Killer Foundation has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skinrange Addiction Killer Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skinrange Addiction Killer Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
